Target intelligence / Profile preview

Gamma-aminobutyric acid-gated chloride channel subunit RDL (RDL) (RDL)

Target
RDL
Molecular classification
Ion channel, Cys-loop ligand-gated ion channel, Receptor
01

Overview

Gamma-aminobutyric acid-gated chloride channel subunit RDL (RDL) is a critical component of the inhibitory neurotransmitter system in the central nervous system of arthropods, including ticks and various insect pests (Ffrench-Constant, 1993). As a member of the Cys-loop ligand-gated ion channel superfamily, it forms homomeric or heteromeric pentameric channels that mediate fast inhibitory synaptic transmission by conducting chloride ions upon GABA binding (Casida & Durkin, 2013). This target is of immense pharmacological importance as it is the site of action for major classes of insecticides and acaricides, such as phenylpyrazoles (e.g., fipronil) and the newer isoxazoline class (e.g., fluralaner, afoxolaner) (Gassel et al., 2014). These drugs function as non-competitive antagonists, binding to an allosteric site within the channel's transmembrane pore to block chloride flow. This blockage leads to neuronal hyperexcitation, paralysis, and death of the parasite (Weber & Selzer, 2016). The therapeutic utility of targeting RDL stems from its high selectivity; structural differences between the invertebrate RDL receptor and the mammalian GABA-A receptor allow these drugs to be highly toxic to parasites while remaining safe for the host (Ozoe, 2013). Resistance to these agents is frequently associated with specific point mutations in the RDL gene, such as the A301S or A301G substitutions, which reduce drug binding affinity (Ffrench-Constant et al., 2000). Consequently, monitoring these mutations is essential for managing resistance in veterinary and agricultural settings.

Other names
GABA-gated chloride channelResistance to dieldrin proteinGABA receptorIonotropic GABA receptorGABA-Cl
02

Mechanism of action

Non-competitive antagonism of the chloride channel pore, leading to hyperexcitation and paralysis of the parasite.

03

Biological functions

Inhibitory neurotransmissionNeuromuscular coordinationSensory processing
04

Disease associations

InfectionEctoparasite infestation
05

Safety considerations

Potential cross-reactivity with mammalian GABA-A receptorsNeurotoxicity in non-target arthropods (e.g., honeybees)Development of drug resistance in parasite populationsEnvironmental persistence of certain antagonists
06

Interacting drugs

Fipronil

8 more in the full profile.

07

Biomarkers

RDL gene mutations (e.g., A301S or A301G)RDL gene expression levels

Beyond the preview

Go deeper on Gamma-aminobutyric acid-gated chloride channel subunit RDL (RDL) (RDL).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma-aminobutyric acid-gated chloride channel subunit RDL (RDL) (RDL).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call